Biofrontera Inc. (NASDAQ:BFRI) Q3 2024 Earnings Conference Call November 14, 2024 10:00 AM ET
Company Participants
Andrew Barwicki - Investor Relations
Hermann Luebbert - Chief Executive Officer, Chairman and Founder
Fred Leffler - Chief Financial Officer
Conference Call Participants
Jonathan Aschoff - ROTH Capital
Bruce Jackson - The Benchmark Company
Operator
Welcome to the Biofrontera Inc. Third Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Andrew Barwicki with Barwicki Investor Relations. Please go ahead.
Andrew Barwicki
Good morning, and welcome to Biofrontera Inc.'s third quarter 2024 financial results and business update conference call.
Please note that certain information discussed during today's call by management is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera's management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera's press releases and SEC filings.
Also, this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, November 14, 2024. Biofrontera undertakes no obligations to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as required by law.
During today's call, there will be references to certain non-GAAP financial measures. Biofrontera believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP, nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in today's press release. More specifically, management will be referencing adjusted EBITDA, a non-GAAP financial measure defined as net income or loss, excluding interest income and expense, income taxes, depreciation and amortization, and certain other nonrecurring or noncash items.
With that said, I would like to turn the call over to Hermann Luebbert, CEO, Chairman and Founder of Biofrontera. Hermann?
Hermann Luebbert
Yes. Thank you, Andrew, and my thanks to everyone joining us this morning.
On today's call, I'll provide an overview of our accomplishments during the third quarter and first nine months of 2024. Fred Leffler, our CFO, will follow with a discussion on financial results. Both of us will be happy to answer questions after our prepared remarks.